The fate of P2Y-related orphan receptors: GPR80/99 and GPR91 are receptors of dicarboxylic acids

Nathalie Suarez Gonzalez, Didier Communi, Sébastien Hannedouche, Jean-Marie Boeynaems, Nathalie Suarez Gonzalez, Didier Communi, Sébastien Hannedouche, Jean-Marie Boeynaems

Abstract

Several orphan G protein-coupled receptors are structurally close to the family of P2Y nucleotide receptors: GPR80/99 and GPR91 are close to P2Y(1/2/4/6/11) receptors, whereas GPR87, H963 and GPR34 are close to P2Y(12/13/14). Over the years, several laboratories have attempted without success to identify the ligands of those receptors. In early 2004, two papers have been published: One claiming that GPR80/99 is an AMP receptor, called P2Y(15), and the other one showing that GPR80/99 is a receptor for alpha-ketoglutarate, while GPR91 is a succinate receptor. The accompanying paper by Qi et al. entirely supports that GPR80/99 is an alpha-ketoglutarate receptor and not an AMP receptor. The closeness of dicarboxylic acid and P2Y nucleotide receptors might be linked to the negative charges of both types of ligands and the involvement of conserved Arg residues in their neutralization.

Figures

Figure 1
Figure 1
Phylogenetic tree illustrating the relatedness of the two groups of P2Y receptors, dicarboxylic acid receptors, receptors for short-chain monocarboxylic acids and remaining orphan P2Y-like receptors. The following receptors are included in the tree: P2Y receptors, group I: P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11; P2Y receptors, group II: P2Y12, P2Y13 and P2Y14; Dicarboxylic acid receptors: succinate (GPR91) and α-ketoglutarate (GPR80/99); Monocarboxylic acid (propionate) receptors: GPR41 and GPR43; Orphan P2Y-like receptors: GPR87, H963 and GPR34. Alignment was performed using ClustalX algorithm and the dendrogram was constructed using the TreeView algorithm.
Figure 2
Figure 2
Role of conserved positively charged residues in the activation of P2Y and dicarboxylic acid receptors by their respective ligands. Conserved residues among P2Y and/or dicarboxylic acids receptors are shown in a higher size font. The residues that have been mutated in the studies of Erb et al. [17], Jiang et al. [14] and He et al. [10] are underlined. Those residues that are crucial in the activation of those receptors are in bold.
Figure 3
Figure 3
Comparison of the responses to α-ketoglutarate (A) and AMP (B) in an aequorin-based functional assay using CHO-K1 cells coexpressing human GPR80/99, apo-aequorin and Gα16. The plasmid was transfected into CHO-K1 cells expressing Gα16 and a mitochondria-targeted form of apoaequorin. Clonal cell lines were established, and functional responses were analyzed using a bioassay based on the luminescence of aequorin, in the presence of 5 µM coelenterazine H, as a result of intracellular calcium release, as described previously [15, 16]. Briefly, cells (25,000 cells in 50 µl) were added to 50-µl samples in 96-well plates, and the luminescence was recorded for 30 s (Berthold luminometer). Maximal response was evaluated following cell lysis by Triton X-100. The ATP response is due to endogenous P2Y2 receptors.

References

    1. Vassilatis DK, Hohmann JG, Zeng H, et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA. 2003;100:4903–4908. doi: 10.1073/pnas.0230374100.
    1. Abbracchio MP, Boeynaems JM, Barnard EA, et al. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci. 2003;24:52–55. doi: 10.1016/S0165-6147(02)00038-X.
    1. Joost P, Methner A. Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol 2002; 3: RESEARCH0063.
    1. Conley P, Vincent D, Tai A, et al. Cloning of a novel purinoceptor from a human megacaryocytic cell line. Blood. 1995;86:316a.
    1. Conley PB, Jantzen HM. Methods of screening for compounds that interact with human P2U2 purinergic receptor. US Patent 6063582, 2000.
    1. Wittenberger T, Schaller HC, Hellebrand S. An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J Mol Biol. 2001;307:799–813. doi: 10.1006/jmbi.2001.4520.
    1. Lee DK, Nguyen T, Lynch KR, et al. Discovery and mapping of ten novel G protein-coupled receptor genes. Gene. 2001;257:83–91. doi: 10.1016/S0378-1119(01)00651-5.
    1. Wittenberger T, Hellebrand S, Munck A, et al. GPR99, a new G protein-coupled receptor with homology to a new subgroup of nucleotide receptors. BMC Genomics. 2002;3:17. doi: 10.1186/1471-2164-3-17.
    1. Inbe H, Watanabe S, Miyawaki M, et al. Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine. J Biol Chem. 2004;279:19790–19799. doi: 10.1074/jbc.M400360200.
    1. He W, Miao FJ, Lin DC, et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature. 2004;429:188–193. doi: 10.1038/nature02488.
    1. Linden J, Thai T, Figler H, et al. Characterization of human A2B adenosine receptors: Radioligand binding, Western blotting, and coupling to Gq in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol. 1999;56:705–713.
    1. Brown AJ, Goldsworthy SM, Barnes AA, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312–11319. doi: 10.1074/jbc.M211609200.
    1. Poul E, Loison C, Struyf S, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278:25481–25489. doi: 10.1074/jbc.M301403200.
    1. Jiang Q, Guo D, Lee BX, et al. A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. Mol Pharmacol. 1997;52:499–507.
    1. Stables J, Green A, Marshall F, et al. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem. 1997;252:115–126. doi: 10.1006/abio.1997.2308.
    1. Blanpain C, Doranz BJ, Vakili J, et al. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J Biol Chem. 1999;274:34719–34727. doi: 10.1074/jbc.274.49.34719.
    1. Erb L, Garrad R, Wang Y, et al. Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J Biol Chem. 1995;270:4185–4188. doi: 10.1074/jbc.270.52.30845.
    1. Qi A-D, Harden TK, Nicholas RA. GPR80/99, proposed to be the P2Y15 receptor activated by adenosine and AMP, is not a P2Y receptor. Purinergic Signalling. 2004;1:67–74. doi: 10.1007/s11302-004-5069-0.

Source: PubMed

3
Suscribir